Higher antidepressant dose may put elderly kidney patients at risk
NCT ID NCT07399795
Summary
This study looked at the safety of two different starting doses of the antidepressant citalopram in adults aged 66 and older who have reduced kidney function. Researchers analyzed health records of over 7,000 people to see if starting on a 20mg daily dose led to more hospital visits, emergency room trips, or death within 30 days compared to starting on a 10mg dose. The goal is to provide clearer guidance to doctors on the safest dose for this vulnerable group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE(CKD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.